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Introduction 
Convergence insufficiency (CI) is defined as a 
condition in which there is greater exophoria at near 
than at distance, a receded near point of convergence, 
and reduced positive fusional vergence at near 
(Rouse et al., 1999; Scheiman & Wick, 2014). 
Individuals with this condition may experience 
symptoms related to near work that interfere with 
school, work, and leisure activities (Borsting, Rouse, 
& De Land, 1999; Rouse et al., 2004; Rouse et al., 
2004). The most effective treatment for convergence 
insufficiency is office-based vergence/ 
accommodative therapy (OBVAT) (Birnbaum, 
Soden, & Cohen, 1999; Scheiman et al., 2008; 
Scheiman, Mitchell, Cotter, et al., 2005; Scheiman, 
Gwiazda, & Li, 2011; Scheiman, Cotter, Kulp, et al., 
2005) which is designed to increase the 
compensatory ability of the visual system (positive 
fusional vergence) to overcome the tendency for the 
eyes to drift outward, and to improve the dynamics 
(velocity, latency, gain) of the disparity vergence 
response. Several randomized clinical trials have 
demonstrated that 12 to 16 weekly, one hour vision 
therapy visits, effectively restore normal clinical 
function in about 75% of children (Convergence 
Insufficency Investigator Group, 2019; Scheiman et 
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al., 2008; Scheiman, Cotter, et al., 2005) and adults 
(Birnbaum et al., 1999; Scheiman, Mitchell, Cotter, 
Kulp, et al., 2005) with symptomatic convergence 
insufficiency. However, the gap in our knowledge is 
that we do not completely understand the underlying 
physiological mechanisms that contribute to the 
reduction in symptoms and improvement in clinical 
findings that have been demonstrated in these clinical 
trials. A better understanding of these mechanisms 
may help researchers and clinicians develop new 
therapy protocols that would improve success rates.  
Prior pilot studies (Alvarez, 2015; Scheiman, 
Talasan, Mitchell, & Alvarez, 2016) suggest that the 
main sequence, a plot of maximum response velocity 
as a function of response amplitude, may be a useful 
tool to better understand how OBVAT improves 
binocular vision function. The original main 
sequence analysis of saccades was utilized to study 
the underlying neural control of saccadic responses 
for a wide range saccadic response magnitudes 
ranging from about 0.5 deg to about 50 deg (Bahill, 
Clark, & Stark, 1975).  For many studies of vergence 
eye movements, the magnitude of the response are of 
a reduced range; hence a main sequence ratio of peak 
velocity divided by response amplitude has been 
investigated to  isolate and explore the 
preprogrammed, fusion-initiating component of 
disparity vergence (Alvarez, 2015; Alvarez, 
Semmlow, Yuan, & Munoz, 1999; Alvarez, 
Semmlow, & Yuan, 1998; Lee, Chen, & Alvarez, 
2008; Munoz, Semmlow, Yuan, & Alvarez, 1999). 
Jones (1980) was the first to describe disparity 
vergence as having a high velocity, fusion-initiating 
component (FIC), which is open-loop with respect to 
the visual stimulus, and a second, slower component, 
the fusion sustaining component (FSC) which is 
feedback controlled (Alvarez et al., 1999; Semmlow, 
Hung, Horng, & Ciuffreda, 1993). The FIC is 
preprogrammed and allows the eyes to quickly rotate 
inward or outward to the new visual target but does 
not always yield accurate movements. The FSC 
provides high accuracy. Since the FSC is feedback 
controlled, it requires time to guide the eyes to the 
desired target and reduce the error (difference 
between the eye’s current location and the desired 
target). One or both components may be modified 
with OBVAT. The main sequence can be used to 
quantitatively analyze the transient portion of 
disparity vergence step responses (also called jump 
ductions) where the FIC dominates the response 
(Alvarez et al., 1999;  Alvarez, Semmlow, & Yuan, 
1998; Hsu, Bahill, & Stark, 1976; Kim, Vicci, Han, 
& Alvarez, 2011; Kim, Vicci, Granger-Donetti, & 
Alvarez, 2011). Thus, analysis of changes in the main 
sequence after rehabilitation may help us understand 
whether significant changes are occurring in the FIC 
component of disparity vergence.  
In a previous study (Scheiman et al., 2016), our 
laboratory studied 5 patients with symptomatic 
convergence insufficiency and concussion (mean age 
22.2 years) and found a significant change in the 
main sequence ratio of convergence after OBVAT 
compared to the baseline measurements (P=0.05). 
Conversely, the main sequence ratio of divergence 
and saccades did not significantly change (P=0.1). 
Our laboratory has published other investigations 
showing optimization of the FIC in binocular normal 
controls after vergence therapy (Talasan, Scheiman, 
Li, & Alvarez, 2016) and in those with CI (Alvarez, 
2015; Alvarez et al., 2010). These results support the 
theory that one of the potential underlying 
mechanisms by which OBVAT leads to a sustained 
reduction in visual symptoms may be through the 
change in the neural control of the FIC.  
The objective of this study is to confirm previous 
research and determine if there are significant 
changes in the disparity vergence main sequence of 
children with symptomatic convergence insufficiency 
after 12 weeks of OBVAT. This information may 
also help to establish the value of the main sequence 
ratio analysis as a useful method to understand the 
underlying mechanism(s) by which OBVAT 
improves disparity vergence and reduces visual 
symptoms in convergence insufficiency patients or 
other binocular vision disorders for future 
randomized clinical trials. 
Methods 
The tenets of the Declaration of Helsinki were 
followed throughout the study. The institutional 
review board of Salus University approved the 
protocol and written informed consent and assent as 
well as Health Insurance Portability and 
Accountability Act (HIPAA) authorization were 
obtained before participation. The trial is registered 
with clinicaltrials.gov (Identifier: NCT03248336, 
date of registration 07/08/2017). 
Patient Selection  
Patients were recruited from the Eye Institute of 
the Pennsylvania College of Optometry at Salus 
University and from the clinical practice of the one of 
the authors (MS). All participants had a 
comprehensive eye examination before the baseline 
visit. To be eligible, individuals had to be between 12 
to 17 years old and have a diagnosis of symptomatic 
convergence insufficiency (CI). Symptomatic CI was 
defined as (1) a score of 16 or higher on the 
convergence insufficiency symptom survey (CISS); 
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(2) exophoria at near at least 4 prism diopters (Δ) 
greater than at distance; (3) a receded near point of 
convergence of ≥ 6 cm break, and (4) insufficient 
positive fusional vergence (i.e., failing Sheard’s 
criterion or positive fusional vergence < 15Δ base-
out) at near. Participants were required to have 20/25 
visual acuity or better with best refractive correction 
if needed. Participants with a previous history of 
vision therapy or brain injury including concussion(s) 
were excluded. The participants also were required to 
have stable general health, intact cognitive function, 
and no other neurological conditions. The full 
eligibility criteria have been published previously 
(Scheiman, Talasan, Alvarez, 2019). 
Study Design 
Clinical testing and objective eye movement 
recording were performed at baseline. After baseline 
measurements, participants received 12, one-hour 
visits of OBVAT. At the completion of therapy, all 
baseline testing was repeated.  
Clinical Testing  
After obtaining written consent/assent, a vision 
examination was performed to determine if the 
patient was eligible for the study. Eligibility testing 
included administration of the Convergence 
Insufficiency Symptom Survey (CISS) to identify 
whether or not the patient was symptomatic (Rouse et 
al., 2009; Rouse et al., 2004). Other eligibility tests 
included best-corrected visual acuity at distance and 
near, a sensorimotor examination [cover test at 
distance and near, near point of convergence (20/30 
target and the Gulden Near Point Rod), positive and 
negative fusional vergence at near (prism bar and a 
held 20/30 vertical line of letters as a target), 
vergence facility (12 base-out, 3 base-in prism) at 
distance and near, near stereoacuity (Randot 
Stereotest), monocular accommodative amplitude 
(20/30 target and the Gulden Near Point Rod), 
monocular accommodative facility (+/-2.00 flipper 
lenses and 20/30 vertical line of letters)], cycloplegic 
refraction, and an ocular health evaluation.  
Objective Outcome Measures of 
Disparity Vergence: Instrumentation 
The ISCAN RK-826PCI binocular tracking 
system (Burlington, MA, USA) recorded horizontal 
vergence eye movements at 240 frames per second 
(Figure 1A).  
 
Figure 1A: Experimental set-up of haploscope used 
to record disparity vergence eye movements. Figure 
1B: ‘Difference of Gaussian’ (DoG) stimulus used for 
all vergence and saccadic testing. 
Stimuli Presentation and Data Collection 
To minimize blur cues and feedback and produce 
virtually accommodative ‘open loop’ conditions 
during the presentation of disparity vergence stimuli, 
a vertically oriented ‘difference of Gaussians’ (DoG) 
(Figure 1B) was used as the disparity vergence step 
stimuli within a traditional haploscope. The use of 4° 
(~7Δ) and 6° (~11Δ) symmetrical disparity steps 
were chosen to maximize the ability to gather quality 
data for each observation. Twelve observations of 
each of the visual stimuli were presented: 4° 
symmetrical disparity vergence steps from a vergence 
angle of 2º to 6º, 4° to 8°, 6º to 10º, 8º to 12º as well 
as 6° symmetrical disparity vergence steps from 6º to 
12º, and from 4º to 10º. This resulted in a total of 72 
convergent movements. The same stimuli were also 
used for divergence steps (72 divergent movements) 
for a total of 144 vergence movements. In addition, 
40 responses each to 5º and 10º saccadic stimuli were 
recorded. 
Calibration  
The participant’s head was restrained using a 
chin/head rest to minimize head movement and 
influence from the vestibular system (Ranjbaran & 
Galiana, 2015). A midline adjustment procedure was 
performed to insure proper positioning within the 
chin/head rest. Calibration consisted of a six-point, 
monocular calibration (1°, 3°, and 5° monocular, 
corresponding to 2°, 6°, 10° binocular vergence angle 
demand, or 4°, 5°, and 6° monocular, corresponding 
to 8°, 10°, 12° binocular vergence angle demand. 
Calibration for saccade responses consisted of a four-
point, monocular calibration (5°, and 10° monocular 
into the left and right visual field). These calibrations 
were performed before and after completion of each 
eye movement response data collection.  
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Eye Movement Analyses 
Eye movement data were processed and analyzed 
with a custom MATLAB program (Waltham, MA, 
USA). All the 4° step vergence data were pooled for 
analysis, as were the 6° step vergence data because 
the outcome measures were not substantially 
different. The vergence eye movements were filtered 
with a 4th order low pass Butterworth filter, with a cut 
off frequency of 40Hz to eliminate instrumentation 
noise especially 60Hz noise that is probably not 
physiological in nature. Saccadic eye movements 
were filtered with a 4th order low pass Butterworth 
filter, with a cutoff frequency of 120Hz. Each 
individual left-eye and right-eye vergence movement 
response was manually inspected for the presence of 
any blink(s) or saccade(s) during any portion of the 
transient portion of the vergence eye movement. 
Saccades were easily identified because saccadic 
dynamics are an order of magnitude greater than 
vergence. Saccades that occurred during the transient 
portion of the vergence response were omitted from 
the peak velocity analysis because several studies 
suggest that saccades influence the maximum 
velocity of vergence (Alvarez & Kim, 2013; Kim & 
Alvarez, 2012; Zee, Fitzgibbon, & Optican, 1992). 
Objective eye movement parameters assessed 
included, latency, time to peak velocity, peak 
velocity and response amplitude. Peak velocity was 
defined as the maximum value of the derivative 
within the transient portion of the vergence 
movement.  
The main sequence ratio was used as the primary 
outcome measure for this study.  The main sequence 
ratio is the peak velocity of the eye movement 
response divided by the response amplitude which is 
the amplitude the response attains within the transient 
portion of the movement. This technique has been 
used in many prior publications (Alvarez, 2015; 
Alvarez, Semmlow, Yuan, & Munoz, 1999; Alvarez, 
Semmlow, & Yuan, 1998; Lee, Chen, & Alvarez, 
2008; Munoz, Semmlow, Yuan, & Alvarez, 1999). 
The strength of the main sequence ratio is that it can 
be used to assess eye movement responses which do 
not have the range of movements as conducted by the 
original main sequence analysis (Bahill et al., 1975). 
Treatment: Office-based Vergence and 
Accommodative Therapy with Home 
Reinforcement (OBVAT) 
Twelve, 60-minute, weekly visits of OBVAT 
were administered by a trained therapist combined 
with procedures to practice at home (15 minutes, 5 
times per week). This treatment sequence is a well-
accepted approach for treatment of convergence 
insufficiency (Alvarez et al., 2010) and has been 
successfully implemented in previous randomized 
clinical trials (Scheiman et al., 2008; Scheiman, 
Mitchell, Cotter, Cooper, et al., 2005). Fifteen 
minutes of home-based therapy was prescribed to be 
performed 5 days per week, and compliance with 
home-based therapy was monitored at each visit by 
the therapist. 
Follow-up Visit  
All participants were re-examined after 
completion of 12 weeks of OBVAT. Both the clinical 
and objective testing performed at enrollment were 
repeated at the outcome examination which occurred 
between 12-14 weeks after baseline.   
Statistical Analysis  
All statistical analyses were performed using 
SPSS Version 24.0 with an alpha level of 0.05 used 
to determine statistical significance. For the main 
sequence analysis, we plotted the peak velocity as a 
function of response amplitude for convergence, 
divergence, and saccades for visual inspection to 
observe the distribution of the data. To determine 
whether significant differences were observed within 
all clinical and objective eye movement recording 
measurements, a two-tailed paired t-test was 
calculated. Effect size was determined using Cohen’s 
d effect size, using Cohen criteria of 0.2 = small 
effect, 0.5 = medium effect, and 0.8 = large effect, 
suggesting meaningful clinical significance. 
Results 
Table 1 illustrates the changes that occurred in 
each clinical measure for the convergence 
insufficiency group from baseline to the outcome 
visit and show statistically significant (P<0.05) and 
clinically meaningful changes in all parameters 
except for the cover test at distance. Ten of the 12 
participants (83%) in the convergence insufficiency 
group were categorized as “successful” based on pre-
determined composite criteria (CISS, near point of 
convergence, positive fusional vergence), and the 
remaining two (participants 6 and 12) “improved”. 
Although these last two participants did not reach the 
required cutoff of <16 on the CISS, in both the CISS 
score decreased by 10 points or more (participant 6 
by 19 points and participant 12 by 36 points). In 
addition, although participant 12 did not fully meet 
the criteria to be labeled “successful”, she did achieve 
the largest decrease in symptoms (36 points) of all 
the participants. 
Tables 2 through 4 show the results of the 
objective eye movement testing which was 
performed at baseline and after 12 sessions (1 hour 
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each) of OBVAT. In Table 2, the data show that for 
both 4° and 6° symmetrical convergence steps, there 
were statistically significant changes in peak velocity, 
time to peak velocity, and response amplitude. The 
data in Table 3 show statistically significant changes 
in peak velocity and response amplitude for 4° and 6° 
symmetrical divergence steps. Table 4 indicates that 
there were no statistically significant changes in 
saccadic eye movements from baseline to the 
outcome examination. All the statistically significant 
findings of mean change after OBVAT have a 
medium to large effect size (>0.5). 
The main sequence plots for convergence (Figure 
2), divergence (Figure 3) and saccades (Figure 4) 
report the P value for the change in the main 
sequence ratio for each type of eye movement 
comparing baseline to outcome measurements. A 
two-tailed paired t-test showed that a significant 
change in the main sequence ratio was observed for 
convergence after OBVAT compared to baseline 
measurements (P=0.007, Cohen’s d=0.5 medium 
effect). The average main sequence ratio (peak 
velocity divided by response amplitude) was 5.7 (sec-
1) ± 1.5 before and changed to 6.2 (sec-1) ± 1.1 after 
OBVAT for convergence eye movements. 
Divergence and saccades did not exhibit significant 
changes in the main sequence ratio after OBVAT 
compared to the baseline measurements. Before 
OBVAT, the divergence main sequence ratio was 6.0 
(sec-1) ± 4.4 and after OBVAT the main sequence 
ratio was 5.2 (sec-1) ± 1.8 (P=0.32). For saccades, the 
main sequence ratio was 38.9 (sec-1) ± 6.6 at baseline 
and 39.7 (sec-1) ± 11.6 after OBVAT (P=0.43). 
 
Table 1: Comparison of Clinical Measures of Convergence Insufficiency Participants Pre-and Post-OBVAT 
Function 
Mean 
Pre-VT 
Mean 
Post VT 
Mean 
Change 
Sig 
Cohen’s d 
Effect Size 
Confidence 
Interval 
CISS 35.8 11.2 24.6 P=0.002 2.84 17.9 to 31.4 
Cover Test (Distance) (Δ)* -0.8 -0.5 0.3 P=0.16 0.16 -0.8 to 0.2 
Cover Test (Near) (Δ)* -9.2 -7.3 1.8 P=0.03 0.43 -3.2 to -0.4 
Base-in Break (Δ) 14.8 19.6 4.8 P=0.02 0.74 -8.1 to -1.4 
Base-out Break (Δ) 11.8 38.3 26.6 P=0.002 3.59 -32.9 to -20.2 
Near point of convergence Break (cm) 16.5 3.6 12.9 P=0.002 4.03 10.2 to 15.6 
Accommodation Amplitude Right Eye (cm) 14.8 8.5 6.3 P=0.003 1.94 3.7 to 8.9 
Vergence Facility (FPM) 8.7 34.8 22.4 P=0.003 2.56 11.6 to 30.8  
Monocular Accommodative Facility (FPM) 7.4 28.3 20.9 P=0.001 2.89 15.4 to 26.3  
*(-) =exophoria 
FPM=Flips per minute 
Δ = prism diopter 
 
Table 2: Comparison of Objective Measures of Convergence Pre- and Post-OBVAT 
4° Symmetrical Convergence 
Function Mean Pre OBVAT 
Mean 
Post 
OBVAT 
Mean 
Change Sig 
Cohen’s d 
Effect Size 
Confidence 
Interval 
Peak Velocity (°/sec) 14.7 26.1 11.4 P=<0.001 1.48 8.3 to 15.0  
Time to Peak Velocity(sec) 0.50 0.40 0.10 P=<0.001 0.99 .07 to .17 
Response Amplitude (°) 2.6 4.1 1.5 P=<0.001 1.31 1.0 to 1.9  
Latency (sec) 0.25 0.22 0.03 P=0.13 0.31 -01 to .07 
6° Symmetrical Convergence 
Peak Velocity (°/sec) 14.7 26.1 11.4 P=<0.001 1.46 8.0 to 14.6  
Time to Peak Velocity(sec) 0.50 0.40 0.10 P=0.01 0.51 0.05 to 0.15 
Response Amplitude (°) 2.6 4.1 1.5 P=<0.001 1.15 1.0 to 1.9  
Latency (sec) 0.23 0.25 0.02 P=0.31 0.12 -0.08 to 0.02 
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Table 3: Comparison of Objective Measures of Divergence Pre- and Post-OBVAT 
4° Symmetrical Divergence 
Function Mean 
Pre 
OBVAT 
Mean Post 
OBVAT 
Mean 
Change 
Sig Cohen’s d 
Effect Size 
Confidence 
Interval 
Peak Velocity (°/sec) 13.5 19.0 5.5 P=,01 0.62 1.4 to 9.6  
Time to Peak Velocity(sec) 0.43 0.40 0.03 P=.25 0.27 -0.03 to 0.09 
Response Amplitude (°) 2.7 3.6 0.9 P=.006 0.69 -0.3 to 1.5 
Latency (sec) 0.21 0.23 0.02 P=0.46 0.16 -0.8 to 0.03 
6° Symmetrical Divergence 
Peak Velocity (°/sec) 15.8 20.3 4.5 P=0.02 0.60 0.8 to 8.2  
Time to Peak Velocity(sec) 0.53 0.56 0.03 P=0.28 0.26 0.05 to 0.15 
Response Amplitude (°) 3.1 4.3 1.2 P=0.001 0.98 0.6 to 1.9 
Latency (sec) 0.20 0.21 0.01 P=0.17 0.33 -0.03 to 0.01 
 
Table 4: Comparison of Objective Measures of Saccades Pre- and Post-OBVAT 
5° Saccades 
Function Mean Pre OBVAT 
Mean Post 
OBVAT 
Mean 
Change Sig 
Cohen’s d 
Effect 
Size 
Confidence 
Interval 
Peak Velocity (°/sec) 202.5 212.8 10.3 P=.12 0.49 -23.7 to 3.1 
Time to Peak Velocity(sec) 0.24 0.27 0.03 P=.35 0.28 -0.09 to 0.03 
Response Amplitude (°) 4.6 4.7 0.1 P=.46 0.22 -0.4 to 0.2 
Latency (sec) 0.23 0.22 0.01 P=.38 0.26 -0.01 to 0.03 
10°Saccades 
Peak Velocity (°/sec) 312.1 312.0 0.1 P=0.99 0.003 -24.9 to 25.1 
Time to Peak Velocity(sec) 0.23 0.23 0.01 P=0.38 0.27 0.01 to 0.03 
Response Amplitude (°) 9.0 8.8 0.2 P=0.68 0.14 -0.4 to 0.6 
Latency (sec) 0.21 0.21 0.01 P=0.55 0.18 -0.01 to 0.02 
 
 
 
Figure 2: Main sequence for convergence pre- vs 
post-OBVAT 
 
Figure 3: Main sequence for divergence pre- vs post-
OBVAT 
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Figure 4: Main sequence for saccades pre- vs post-
OBVAT 
Discussion 
The results of this study are consistent with 
previous clinical trials (Scheiman et al., 2008; 
Scheiman, Cotter, et al., 2005; Scheiman, Talasan, & 
Alvarez, 2019; Scheiman et al., 2016) and show 
statistically significant and clinically meaningful 
changes in clinical and objective measures of 
vergence in participants with symptomatic 
convergence insufficiency treated with OBVAT for 
12 weeks. The new contribution from this study is 
that statistically significant changes were also found 
for the main sequence ratio for convergence step 
responses, while there were no significant changes 
for either divergence or saccades responses post-
OBVAT. This is not surprising since most of the 
therapy time was designed to improve convergence. 
The strength of a main sequence analysis which can 
be quantified as the main sequence ratio is it is an 
assessment of the underlying neural control of the 
responses. The main sequence analysis assesses 
whether the responses are simply scaled movements 
or whether the first-order dynamics are indeed 
different.  The primary finding of this study is that 
the main sequence ratio of convergence significantly 
changed which supports a neural control change post 
OBVAT, whereas divergence and saccadic responses 
were not significantly different from a neural control 
aspect. Divergence peak velocity and response 
amplitude significantly changed but the main 
sequence ratio did not. Hence, the divergence 
responses were generated using similar neural control 
and post OBVAT the divergence responses were 
larger in magnitude and speed. Conversely, not only 
did convergence movement increase in speed and 
magnitude, the main sequence ratio or the neural 
control strategy was significantly different post-
OBVAT.  
Neurophysiological studies support that ‘velocity-
encoding’ burst cells are observed within the 
oculomotor nucleus within the brainstem (Mays, 
Porter, Gamlin, & Tello, 1986). These cells are 
responsible for the bursting activity to move the eyes 
quickly to the visual target but do not necessarily do 
so very accurately (Chen, Lee, Chen, Semmlow, & 
Alvarez, 2010; Semmlow, Yuan, & Alvarez, 2002). 
Adaptive changes corresponding to modifications in 
peak velocity and vergence response amplitudes is 
modeled as an improvement to the fusional-initiating 
component. These data of the present study report 
significant changes in peak velocity and the main 
sequence ratio. Hence, these data support that one of 
the underlying physiological changes that occur after 
OBVAT is optimization of the fusion-initiating 
component of convergence. 
Vergence therapy can generally be performed two 
ways (Scheiman & Wick, 2014). The first method is 
using a ramp or tonic vergence stimulus. In a 
ramp/tonic vergence procedure, the vergence demand 
is increased in a gradual manner. The second method 
is phasic or step vergence therapy. In a phasic/step 
procedure, the vergence demand is changed in 
discrete steps and speed of the response is 
emphasized. Some research has been done comparing 
the effectiveness of these two types of procedures 
(Daum, 1983). This evidence suggests that both 
procedures are effective in producing gains in 
fusional vergence, although phasic/step vergence 
therapy shows the greatest improvements (Daum, 
1983). Typically, both types of procedures are 
utilized with a patient undergoing OBVAT. Given 
that the main sequence ratio is a surrogate for the 
fusion-initiating component described within the 
Dual Mode model of disparity vergence, the results 
of this study emphasize the importance of phasic/step 
vergence when planning a OBVAT program for 
convergence insufficiency (Yuan, Semmlow, 
Alvarez, & Munoz, 1999). The objective of this type 
of therapy is to improve the dynamics of the vergence 
response which may optimize the fusion-initiating 
component. When the fusion-initiating component is 
enhanced, meaning it brings the eyes closer to the 
intended visual stimulus, less adjustment is needed 
by the fusion-sustaining component.   
While OBVAT has been shown to be an effective 
treatment for convergence insufficiency 
(Convergence Insufficency Investigator Group, 2019; 
Scheiman et al., 2008; Scheiman, Cotter, et al., 2005; 
Scheiman, Gwiazda, et al., 2011; Scheiman, Mitchell, 
Cotter, Kulp, et al., 2005) and accommodative 
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disorders (Scheiman, Cotter, et al., 2011), these 
studies show about 25% of participants do not 
achieve a successful outcome after this treatment. 
Thus, there is a need to better understand the 
underlying mechanisms that explain the improvement 
in vision function after vison therapy.  Such 
information will help clinicians understand how to 
modify OBVAT protocols to improve success rates. 
There are a few study limitations. The lack of 
either a placebo control group or an untreated control 
group prevents us from definitively ruling out other 
potential reasons for improvement in the outcome 
data (such as the placebo effect, Hawthorne effects, 
regression to the mean, etc.). However, the 
significant differential effects on convergence 
compared to no significant change on divergence or 
saccadic responses in terms of the neural control 
strategy as assessed by the main sequence ratio does 
support that OBVAT changed the convergence 
system in a different manner compared to the 
divergence or saccadic systems. Previous studies 
(Convergence Insufficency Investigator Group, 2019; 
Scheiman et al., 2008; Scheiman, Mitchell, Cotter, 
Cooper, et al., 2005; Scheiman, Mitchell, Cotter, 
Kulp, et al., 2005; Talasan et al., 2016) in which a 
placebo control group was used, suggest that the 
observed effects were treatment-related. Another 
potential issue is whether the repetitions of vergence 
movements during the assessment could have 
changed the vergence dynamics. There are studies 
showing, that repetition during an assessment 
changes transient vergence dynamics (Jainta, Bucci, 
Wiener-Vacher, & Kapoula, 2011; Yuan & 
Semmlow, 2000). However, the same effect of 
repetition was present at baseline and outcome and 
likely cancelled any effect on the actual mean 
change. Finally, the protocol used to objectively 
assess disparity only included step vergence stimuli 
and did not include ramp stimuli which can provide 
constant stimulation for the fusion-sustaining 
component. Thus, the stimulus used within this study 
concentrates on the fusion-initiating component. In 
future studies, the design should also incorporate 
ramp stimuli of slower speeds which prior study 
support studies the fusion sustaining component 
(Alvarez, Gayed, & Semmlow, 2006; Alvarez, 
Semmlow, & Pedrono, 2007; Lee et al., 2008; 
Lestrange, Talasan, & Alvarez, 2014; Yaramothu & 
Alvarez, 2014). Ultimately, it will be necessary to 
perform several clinical trials comparing the 
effectiveness of therapy designed to treat the two 
components described within the dual-mode theory. 
Future research may wish to include a phoria 
adaptation and fixation disparity analysis at baseline 
and as an outcome measure for OBVAT to assess 
changes to the slow fusion system of vergence 
(Brautaset & Jennings, 2005) and the error within the 
disparity vergence system (Schor, 1980). Neither of 
these were investigated within this present study and 
would facilitate a broader understanding of how 
OBVAT influences the vergence system.  
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